Back to Pulmonology
Pulmonologyv2014Evidence-Based

Bova Score for Pulmonary Embolism Complications

Predicts 30-day risk of PE-related complications (death, hemodynamic collapse, or recurrent PE) in hemodynamically stable patients with confirmed pulmonary embolism

Clinical Input Parameters

mmHg
Range: 90 — 300 mmHg
beats/min
Range: 30 — 250 beats/min
Clinical Assessment
Awaiting Parameters
bova score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Bova Score for Pulmonary Embolism Complications is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pulmonology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Bova Score = (sBP 90-100: 2 points) + (Elevated troponin: 2 points) + (RV dysfunction: 2 points) + (HR ≥110: 1 point)

Clinical Pearls & Practice Notes

  • Only applicable to hemodynamically stable patients (systolic BP ≥90 mmHg)
  • Requires cardiac troponin measurement and imaging (TTE or CT) for RV assessment
  • PE-related complications include death, hemodynamic collapse, or recurrent PE within 30 days
  • Not validated for hemodynamically unstable patients or those with systolic BP <90 mmHg
  • Should be used in conjunction with clinical judgment and institutional protocols

Evidence & Literature Citations

  1. Bova C, Sanchez O, Prandoni P, Lankeit M, Konstantinides S, Vanni S, et al. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J. 2014 Sep;44(3):694-703. doi: 10.1183/09031936.00006114.
  2. Fernández C, Bova C, Sanchez O, Prandoni P, Lankeit M, Konstantinides S, et al. Validation of a Model for Identification of Patients at Intermediate to High Risk for Complications Associated With Acute Symptomatic Pulmonary Embolism. Chest. 2015 Jul;148(1):211-218. doi: 10.1378/chest.14-2551.

Score Interpretation Ranges

Stage I0 – 2 pts

Low risk

Stage II3 – 4 pts

Intermediate risk

Stage III5 – 7 pts

High risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.